3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
147
Breast Neoplasms
108
Lung Neoplasms
93
Carcinoma, Non-Small-Cell Lung
78
Neoplasm Metastasis
68
Glioblastoma
68
Brain Neoplasms
65
Glioma
59
Pancreatic Neoplasms
46
Carcinoma, Renal Cell
43
Multiple Myeloma
41
Squamous Cell Carcinoma of Head and Neck
39
Colorectal Neoplasms
39
Lymphoma, Large B-Cell, Diffuse
37
Neoplasms
34
Melanoma
33
Lymphoma
32
Carcinoma, Hepatocellular
32
Urinary Bladder Neoplasms
31
Ovarian Neoplasms
29
Astrocytoma
28
Sarcoma
25
Oropharyngeal Neoplasms
24
Lymphoma, Follicular
23
Central Nervous System Neoplasms
23
Rectal Neoplasms
22
Uterine Cervical Neoplasms
21
Triple Negative Breast Neoplasms
21
Mouth Neoplasms
21
Lymphoma, Non-Hodgkin
21
Interventions
Gemcitabine
30
Mitomycin
25
BCG Vaccine
11
Docetaxel
10
Epirubicin
6
erdafitinib
5
durvalumab
5
Radiotherapy
5
dodecyl maltoside
4
apaziquone
4
tislelizumab
3
Cystoscopy
3
ALT-803
3
viscum album peptide
2
pembrolizumab
2
disitamab vedotin
2
avelumab
2
VB4-845
2
Therapeutics
2
Imiquimod
2
Hyaluronic Acid
2
5-aminolevulinic acid hexyl ester
2
1-phenyl-3,3-dimethyltriazene
2
vocimagene amiretrorepvec
1
valrubicin
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled